Myers, R M <br/><br/>
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Dec 2007 
 - 700-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/sj.clpt.6100409  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Cell Line, Tumor<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Humans<br/>Injections, Intravenous<br/>Measles virus--genetics<br/>Membrane Cofactor Protein--genetics<br/>Mice<br/>Mice, Inbred ICR<br/>Mice, SCID<br/>Mice, Transgenic<br/>Multiple Myeloma--drug therapy<br/>Oncolytic Virotherapy--adverse effects<br/>Oncolytic Viruses<br/>RNA, Viral--isolation & purification<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Saimiri<br/>Symporters--administration & dosage<br/>Transplantation, Heterologous